Comparing the Efficacy and Safety of Apixaban and Warfarin in Patients with Atrial Fibrillation and Advanced Chronic Kidney Disease

被引：0
|
作者：
Asgar, Juzer Ali [1 ]
Benchakroun, Amal [2 ]
Sass, Nicholas [3 ]
Hassani, Samar [3 ]
Efuet-Ateh, Leonard [1 ]
Koss, Harrison [1 ]
Jones, Can [4 ,5 ,6 ,7 ]
Ostos, Catherine
Alvarado, Francisco [1 ]
Chait, Robert [1 ]
机构：
[1] Univ Miami, Ctr Tratamiento Intens, Miller Sch Med, HCA JFK Med Ctr Palm Beach Reg Campus, Atlantis, FL USA
[2] Univ Miami, Miller Sch Med, HCA JFK Med Ctr Palm Beach Reg Campus, Atlantis, CA USA
[3] HCA East Florida JFK Med Ctr, Atlantis, FL USA
[4] Mem Healthcare Syst, Dept Hematol & Oncol, Pembroke Pines, FL USA
[5] Mem Healthcare Syst, Dept Hematol & Oncol, Miramar, FL USA
[6] Univ Miami, JFK Med Ctr Palm Beach Reg GME Consortium Interna, Internal Med, W Palm Beach, FL USA
[7] Natl Canc Inst Hematol Oncol Clin Fellowship, NIH, Bethesda, MD USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-212201
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5583 / 5584
页数：2
相关论文
共 50 条
  • [41] Warfarin utilisation and anticoagulation control in patients with atrial fibrillation and chronic kidney disease
    Yang, Felix
    Hellyer, Jessica A.
    Than, Claire
    Ullal, Aditya J.
    Kaiser, Daniel W.
    Heidenreich, Paul A.
    Hoang, Donald D.
    Winkelmayer, Wolfgang C.
    Schmitt, Susan
    Frayne, Susan M.
    Phibbs, Ciaran S.
    Turakhia, Mintu P.
    HEART, 2017, 103 (11) : 818 - 826
  • [42] Efficacy and safety of the novel oral factor Xa inhibitor apixaban in atrial fibrillation (AF) patients with chronic kidney disease (CKD): the AVERROES trial
    Hart, R. G.
    Eikelboom, J.
    Yusuf, S.
    Gao, P.
    Paolasso, E.
    De Caterina, R.
    Husted, S.
    Connolly, S. J.
    EUROPEAN HEART JOURNAL, 2011, 32 : 6 - 6
  • [43] Risk of All Cause Stroke and Major Bleeding Events When Switching From Warfarin to Apixaban in Patients With Advanced Chronic Kidney Disease and Prevalent Atrial Fibrillation
    Garlo, Katherine
    Mavrakanas, Thomas
    Burdick, Elisabeth
    Wang, Wei
    Charytan, David
    STROKE, 2021, 52
  • [44] EFFECTIVENESS AND SAFETY OF APIXABAN, RIVAROXABAN AND WARFARIN IN PATIENTS WITH ADVANCED CKD AND ATRIAL FIBRILLATION: A NATIONWIDE US COHORT STUDY
    Fu, Edouard
    Desai, Rishi
    Paik, Julie
    Kim, Dae
    Zhang, Yichi
    Mastrorilli, Julianna
    Cervone, Alexander
    Lin, Joshua
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I130 - I132
  • [45] CASE REPORT: EFFICACY AND SAFETY OF EDOXABAN IN ELDERLY PATIENT WITH ATRIAL FIBRILLATION AND ADVANCED CHRONIC KIDNEY DISEASE
    Carbone, S.
    Capasso, F.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0G) : G142 - G142
  • [46] Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE Trial
    Melloni, Chiara
    Dunning, Allison
    Granger, Christopher B.
    Thomas, Laine
    Khouri, Michel G.
    Garcia, David A.
    Hylek, Elaine M.
    Hanna, Michael
    Wallentin, Lars
    Gersh, Bernard J.
    Douglas, Pamela S.
    Alexander, John H.
    Lopes, Renato D.
    AMERICAN JOURNAL OF MEDICINE, 2017, 130 (12): : 1440 - +
  • [47] Efficacy and safety of apixaban versus warfarin in patients with atrial fibrillation and active cancer: insights from the ARISTOTLE trial
    Melloni, C.
    Dunning, A.
    Granger, C. B.
    Thomas, L.
    Khouri, M.
    Garcia, D. A.
    Hylek, E. M.
    Wallentin, L.
    Gersh, B. J.
    Douglas, P. S.
    Alexander, J. H.
    Lopes, R. D.
    EUROPEAN HEART JOURNAL, 2016, 37 : 234 - 234
  • [48] COMPARATIVE EFFICACY AND SAFETY OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION AND CHRONIC KIDNEY DISEASE
    Gorbatenko, V. S.
    Gerasimenko, A. S.
    Shatalova, O., V
    KARDIOLOGIYA, 2020, 60 (09) : 102 - 109
  • [49] Efficacy and safety of edoxaban in patients with atrial fibrillation (AF) and severe chronic kidney disease (CKD)
    Lamaida, Norman
    Torella, Giorgio
    Cerciello, Antonio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N25 - N26
  • [50] Critique of Apixaban Versus Warfarin in Patients With Atrial Fibrillation
    Nedeltchev, Krassen
    STROKE, 2012, 43 (03) : 922 - 923
12345